Ryosuke Imai
Overview
Explore the profile of Ryosuke Imai including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
61
Citations
772
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nakamura T, Jinta T, Kitamura A, Tanaka M, So C, Ro S, et al.
Cureus
. 2025 Mar;
17(2):e78750.
PMID: 40070627
Background Although antifibrotic agents (AFAs) are often discontinued due to side effects, their tolerability is crucial given the limited treatment options for interstitial lung disease associated with connective tissue disease...
2.
Yamamoto S, Horita N, Imai R, Niitsu T
Lung
. 2025 Jan;
203(1):22.
PMID: 39762564
Background: Along with lung volume reduction surgery (LVRS), bronchoscopic lung volume reduction is a treatment option for end-stage emphysema. However, comparisons among interventions remain insufficient. Methods: We searched on PubMed,...
3.
Imai R, Tomishima Y, Nakamura T, Yamada D, Ro S, So C, et al.
Ann Am Thorac Soc
. 2024 Nov;
22(3):387-394.
PMID: 39531620
Equivocal interstitial lung abnormality (ILA) involves less than 5% of any lung zone or presents unilaterally without satisfying the diagnostic criteria for ILA. However, the prevalence and prognosis of equivocal...
4.
Satake A, Imai R, Fujino T, Tomimoto S, Ohta K, Naiem M, et al.
Elife
. 2024 Oct;
12.
PMID: 39441734
The rates of appearance of new mutations play a central role in evolution. However, mutational processes in natural environments and their relationship with growth rates are largely unknown, particular in...
5.
Nishihara M, Imai R, Ushigusa T, Nakamura T, So C, Okafuji K, et al.
Intern Med
. 2024 Aug;
PMID: 39111888
Pulmonary sclerosing pneumocytoma (PSP) is a rare, benign tumor. Given the challenges of a bronchoscopic diagnosis, surgery is performed during the early stages of the disease. Therefore, little is known...
6.
Asao T, Shukuya T, Uemura K, Kitadai R, Yamamoto G, Mouri A, et al.
Lung Cancer
. 2024 Jul;
194:107894.
PMID: 39029359
Background: The risk and survival of patients with non-small cell lung cancer (NSCLC) with pre-existing autoimmune disorders (AIDs) receiving immune checkpoint blockade (ICB) therapy have not been clearly established. Patients...
7.
Tomishima Y, Kitamura A, Imai R, Ohde S
BMC Pulm Med
. 2024 Jun;
24(1):290.
PMID: 38909185
Background: Interstitial pneumonia and emphysema may complicate patients with lung cancer. However, clinical significance of trivial and mild pulmonary abnormalities remains unclear. In this study, we aimed to investigate whether...
8.
Shirasaki K, Hifumi T, Sekiguchi M, Isokawa S, Nakao Y, Tanaka S, et al.
Acute Med Surg
. 2024 Jan;
11(1):e926.
PMID: 38283103
Aim: The present study aimed to describe in detail the changes to and assess the risk factors for poor long-term outcomes of psychiatric disorders in families of COVID-19 patients. Methods:...
9.
Oyama R, Ishigame H, Tanaka H, Tateshita N, Itazawa M, Imai R, et al.
ACS Nano
. 2023 Oct;
17(19):18758-18774.
PMID: 37814788
RNA vaccines based on lipid nanoparticles (LNPs) with transcribed mRNA (IVT-mRNA) encapsulated are now a currently successful but still evolving modality of vaccines. One of the advantages of RNA vaccines...
10.
Imai R, Kitamura A
Respirol Case Rep
. 2023 Jul;
11(8):e01193.
PMID: 37484711
In this report, a modified regimen based on IMpower 133 (carboplatin + etoposide + atezolizumab) was administered to a patient diagnosed with large cell neuroendocrine carcinoma (LCNEC) who was concurrently...